Insights from 2023 ASCO® Annual Meeting
A

ASCO® 2023 Insights: "FGFR 2.0 in BTC - Is There a Best in Class?"

By Insights from 2023 ASCO® Annual Meeting FEATURING Arndt Vogel
By Insights from 2023 ASCO® Annual Meeting FEATURING Arndt Vogel
203 views
June 21, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
22:55
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON…

Feat. R. Kim, R. Mehta
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
27:04
Fengting Yan

Cancer Screening Molecular Tools

06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
13:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…

Feat. V. Subbiah
16:40
Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

Feat. R. Kim, T. Biachi
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

06:03
Total Health

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Feat. A. Grothey
28:25
Integrity Continuing Education

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Feat. V. Lee, E. Christenson, N. Bhagat, E. Winslow
12:04
Arndt Vogel

Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions

08:24
Yale Cancer Center

GI Oncology Year in Review: Hepatobiliary Cancers

Feat. P. Kunz
14:54
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…

Feat. L. Rimassa
14:33
Insights from 2023 ESMO Annual Meeting

Personalized Medicine and Targeted Agents for Biliary Tract Cancer

Feat. L. Rimassa
22:33
Integrity Continuing Education

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Feat. V. Lee, R. Kumar, N. Bhagat, E. Winslow
09:03
Integrity Continuing Education

Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management

Feat. J. Birkness-Gartman
04:39
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor …

Feat. G. Abou-Alfa
29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

12:21
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Great Debate: Neoadjuvant vs. Adjuvant Therapy for High-Risk BTC - P…

Feat. M. Yarchoan